Unknown

Dataset Information

Chemotherapy for metastatic colon cancer: No effect on survival when the dose is reduced due to side effects.


ABSTRACT: BACKGROUND:5-Fluorouracil (5FU), Folinic acid (FA), and Oxaliplatin (FOLFOX) or 5FU, FA, and Irinotecan (FOLFIRI) are standard regimens for palliative chemotherapy of metastatic colon cancer. Since data showing the influence of dose reduction in palliative treatment are rare, the objective of this single center, retrospective study was to further characterize the influence of dose reduction on efficacy of these therapeutic regimens. METHODS:One hundred nine patients, diagnosed with stage IV colon cancer between 2004 and 2012 and receiving palliative first-line chemotherapy with either FOLFOX or FOLFIRI regimens in our outpatient clinic were analyzed for treatment efficacy. Patients who received dose reductions due to side effects usually received doses of 80% or lower of per protocol dose.

SUBMITTER: Munker S 

PROVIDER: S-EPMC5913883 | biostudies-literature | 2018 Apr

REPOSITORIES: biostudies-literature